Free Trial
OTCMKTS:NVTRQ

Nuvectra (NVTRQ) Stock Price, News & Analysis

$0.02 -0.01 (-25.00%)
As of 06/2/2020

About Nuvectra Stock (OTCMKTS:NVTRQ)

Key Stats

Today's Range
$0.02
$0.02
50-Day Range
$0.0150
$0.0150
52-Week Range
$0.01
$4.30
Volume
382,600 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nuvectra Corporation, a neurostimulation medical device company, develops and commercializes neurostimulation technology platform for the treatment of various disorders in neuroscience and clinical markets. The company offers Algovita, a spinal cord stimulation system for the treatment of chronic intractable pain of the trunk and limbs. It is also developing Virtis, a sacral neuromodulation (SNM) system for the treatment of chronic urinary retention and overactive bladder; and technologies to support other indications, including SNM for the treatment of overactive bladder and deep brain stimulation to treat Parkinson's disease. The company serves hospitals, surgery centers, and medical facilities through a direct sales force and third-party distributors in the United States and Europe. Nuvectra Corporation was founded in 2008 and is headquartered in Plano, Texas.

Receive NVTRQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuvectra and its competitors with MarketBeat's FREE daily newsletter.

NVTRQ Stock News Headlines

Imasen Electric Industrial Co Ltd (7266)
This document could hand you a shot at $915 every single weekend!
Something fascinating happens in the options market when most traders aren't paying attention… While everyone else collects standard daily premiums Monday through Friday... There's a special opportunity to target TRIPLE premiums just for holding positions over the weekend. Think about that... Most traders get one day's worth of premium for their trades. But by entering right before the weekend, when everything works out, you could collect THREE days worth - even though markets are closed for two of them. Thanks to a special discovery by a Wall Street legend who helped manage a $1.7 trillion firm – regular folks like you can now target extra cash from the markets on weekends… Just like he showed his small group of traders on December 20th with KO... A quick 2-minute setup Friday afternoon… Head out for the weekend... Monday morning? An extra $1,111 sitting in the account (with a $5k starting stake).
See More Headlines

NVTRQ Stock Analysis - Frequently Asked Questions

Nuvectra's stock was trading at $0.0150 at the beginning of the year. Since then, NVTRQ stock has increased by 0.0% and is now trading at $0.0150.
View the best growth stocks for 2025 here
.

Nuvectra Corp (OTCMKTS:NVTRQ) announced its quarterly earnings data on Monday, October, 29th. The company reported ($0.87) earnings per share for the quarter, missing analysts' consensus estimates of ($0.86) by $0.01. The firm earned $14.22 million during the quarter, compared to the consensus estimate of $12.38 million.

Shares of NVTRQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
10/29/2018
Today
5/31/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:NVTRQ
Previous Symbol
NASDAQ:NVTRV
Fax
N/A
Employees
197
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (OTCMKTS:NVTRQ) was last updated on 5/31/2025 by MarketBeat.com Staff
From Our Partners